APOE and early-onset autosomal dominant Alzheimer disease: A further study of 162 adults who had a living or deceased parent with Alzheimer’s disease and were randomized to receive or not receive their own APOE genotype showed that some participants randomized to the nondisclosure group were dissatisfied at not receiving their genotyping results [80].